Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VERTEX PHARMACEUTICALS

(VRTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart VERTEX PHARMACEUTICALS
Upcoming events on VERTEX PHARMACEUTICALS
10/27/21 Q3 2021 Earnings Release (Projected)
02/02/22 FY 2021 Earnings Release (Projected)
04/28/22 Q1 2022 Earnings Release (Projected)
07/27/22 Interim 2022 Earnings Release (Projected)
Past events on VERTEX PHARMACEUTICALS
09/15/21 | 11:00am Morgan Stanley Global Healthcare Conference
07/29/21 | 05:30pm Interim 2021 Earnings Call
07/29/21 | 04:01pm Interim 2021 Earnings Release
06/11/21 | 03:00am European Hematology Association Congress - Abstract #EP736
06/11/21 | 03:00am European Hematology Association Congress - Abstract #EP733
06/10/21 | 04:30pm VX-864 Phase 2 Study Results Call
05/19/21 Annual General Meeting
05/13/21 | 10:15am Bank of America Healthcare Conference
04/29/21 | 05:30pm Q1 2021 Earnings Call
04/29/21 | 04:01pm Q1 2021 Earnings Release
Past dividends on VERTEX PHARMACEUTICALS

- No events available -

Annual results
Fiscal Period : December201620172018201920202021
Sales
M $
Released
Forecast
Spread
1 702
1 696
0,38%
2 489
2 431
2,4%
3 048
2 992
1,9%
4 163
3 759
11%
6 206
6 159
0,76%
 
7 269
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
71,3
58,7
22%
185
119
56%
1 184
1 123
5,4%
1 893
1 770
6,9%
3 601
3 649
-1,3%
 
4 333
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
288
278
3,8%
564
538
4,9%
1 112
1 052
5,7%
1 786
1 609
11%
3 491
3 471
0,58%
 
4 133
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-67,4
-91,9
27%
-15,7
-70,5
78%
600
771
-22%
1 395
964
45%
3 117
2 891
7,8%
 
2 468
 
Net income
M $
Released
Forecast
Spread
-112
-135
17%
263
237
11%
2 097
740
183%
1 177
796
48%
2 712
2 608
4,0%
 
2 082
 
EPS
$
Released
Forecast
Spread
-0,46
-0,55
17%
1,04
0,90
15%
8,09
2,84
185%
4,51
3,08
46%
10,3
9,87
4,2%
 
8,02
 
Announcement Date01/25/201701/31/201802/05/201901/30/202002/01/2021-
Quarterly results
Fiscal Period : December2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
Sales
M $
Released
Forecast
Spread
1 524
1 393
9,4%
1 538
1 480
3,9%
1 628
1 585
2,7%
1 724
1 657
4,1%
1 793
1 726
3,9%
 
1 845
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
901
875
2,9%
881
890
-1,1%
916
1 001
-8,5%


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
874
725
21%
854
797
7,2%
887
872
1,7%
1 003
921
8,8%
1 029
949
8,5%
 
1 021
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
825
569
45%
746
658
13%
889
704
26%
821
759
8,2%
-44,3
188
-124%
 
846
 
Net income
M $
Released
Forecast
Spread
837
433
93%
667
523
28%
604
577
4,8%
653
615
6,1%
66,9
110
-39%
 
676
 
EPS
$
Released
Forecast
Spread
3,18
1,66
91%
2,53
1,98
28%
2,30
2,13
8,2%
2,49
2,29
8,7%
0,26
0,69
-62%
 
2,57
 
Announcement Date07/30/202010/29/202002/01/202104/29/202107/29/2021-
Previous year Next Year
Upcoming sector events for VERTEX PHARMACEUTICALS
More events
Past sector events for VERTEX PHARMACEUTICALS
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise